Kemal Malik

Kemal Malik (board member) discloses dealings in 2 companies, chiefly Cartesian Therapeutics, Inc. and Acceleron Pharma Inc. In total, 5 filings cover trades dated from 29 January 2021 to 2 January 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 6 January 2026: a share grant, in Cartesian Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.